They started out as a useful tool for studying the immune system in the lab and now they’re a family of drugs treating millions of patients, with global revenues of …
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Krishan Maggon 's curator insight,
October 9, 2014 3:13 AM
open access Annals of Medicine and Surgery Volume 3, Issue 4, December 2014, Pages 113–116 Open AccessReview The history of monoclonal antibody development – Progress, remaining challenges and future innovationsJustin K.H. Liu, Show moreDOI: 10.1016/j.amsu.2014.09.001Get rights and contentUnder a Creative Commons license |
Key MABs timelines 40 years